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Background: To determine whether matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMP-1 and
TIMP-2) in human follicular fluid, have any relationships with oocyte maturation in vivo and subsequent fertilization
during in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) cycles.
Methods: The follicular fluids were obtained from 150 female patients undergoing IVF/ICSI cycles and a total of
1504 oocytes were retrieved for analysis. MMP-2 and MMP-9 activities were measured using zymography assay.
TIMP-1 and TIMP-2 concentrations were quantitatively assessed using enzyme-linked immunosorbent assay (ELISA).
Results: Human follicular fluid MMP-2 level was significantly associated with the rate of maturity of oocytes
(P < 0.001). Furthermore, the MMP-2 was significantly associated with the higher fertilization rate (P < 0.01). There
was no significant correlation between follicular MMP-9 and the maturation rate of oocytes. The TIMP-1 and TIMP-2
also showed no correlation with the oocyte maturation rate.
Conclusions: The level of gelatinase MMP-2 in human follicular fluid might be a reliable marker of mature oocytes
during IVF/ICSI cycles. Furthermore, the MMP-2 expression has a strong association with higher fertilization rate.
Further studies are needed to support this theory.
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matrix metalloproteinaseBackground
During an assisted reproductive technology cycle, human
pregnancy is dependent on a number of physiologic condi-
tions, including oocyte maturation, successful fertilization,
and embryonic blastocyst development [1, 2]. Currently,
the clinical prediction of oocyte maturation in in vitro
fertilization (IVF) / intracytoplasmic sperm injection (ICSI)
cycles mainly depend on the size of leading follicles
(>17 mm in diameter) and are sometimes accompanied by
serum estradiol level. However, there is still no accurate
marker for the prediction of the maturation of oocytes.* Correspondence: hssypp@yahoo.com.tw; lincs@mail.nctu.edu.tw
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shown to be important in the follicular microenvironment,
as well as subsequent ovulation [3–5]. MMPs are a family
of zinc endopeptidases capable of degrading all of the
components of the extracellular matrix (ECM) and are di-
vided into sub-groups depending on the specificity of the
substrates [6]. Matrix metalloproteinase-2 (MMP-2) and
matrix metalloproteinase-9 (MMP-9) belong to gelatinases
and their activities are specifically inhibited by tissue inhib-
itors of metalloproteinases (TIMPs). Tissue inhibitor of
metalloproteinase-1 (TIMP-1) has a higher affinity for
MMP-9, while tissue inhibitor of metalloproteinase-2
(TIMP-2) has a higher affinity for MMP-2 [6–8]. In
addition, MMP and TIMP proteins have been detected in
the sperm-oocyte interaction. This finding might suggests distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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ation and subsequent fertilization [9].
The production of MMPs and TIMPs as well as the
mechanisms of action in the follicular microenvironment
are important for subsequent follicular development.
Deficient follicular growth and/or ovulation are corre-
lated with the presence of low levels of MMPs in follicu-
lar fluid [3, 4]. Gelatinases have an important role in the
stabilization of the ECM, an important process during
the initiation of pregnancy [5, 6]. In IVF/ICSI cycles, it is
well-known that not all oocytes retrieved after controlled
ovarian hyper-stimulation show the same potential for
achieving maturity. Between 5 and 20 % of retrieved oo-
cytes are immature and have a low fertilization rate [10].
Therefore, the accurate marker of the maturity rate of
retrieved oocytes is important for the success of assisted
reproductive technologies. We wondered whether the
expression of MMPs (MMP-2 and MMP-9) and TIMPs
(TIMP-1 and TIMP-2) in follicular fluid during the IVF/
ICSI cycle is related to the maturity of oocytes and
sought to find whether MMPs in follicular fluid are a re-




This prospective study included IVF/ICSI cycles during
the period from 2010–2013 in the Fertility Unit of Ton-
Yen General Hospital, Taiwan. To minimize confound-
ing factors, patients diagnosed with polycystic ovaries
and a poor response (< two retrieved oocytes and serum
estradiol [E2] level ≤ 300 pg/ml on the day of human
chorionic gonadotrophin [hCG] administration) were ex-
cluded from the study. Patients with male factor infertil-
ity (which was defined by the presence of any of the
following parameters: sperm concentration < 20 × 106/ml;
total motility < 40 %; and normal morphology < 4 %) were
treated with ICSI, while others were treated with conven-
tional insemination for IVF. The study was performed
with the approval of the Institutional Review Board of
Ton-Yen General Hospital. All participants provided writ-
ten informed consent to participate in this study.
Ovarian stimulation
One hundred and fifty patients who underwent IVF/ICSI
were included in this study. Briefly, all of the patients
used a GnRH antagonist protocol. Recombinant follicle
stimulating hormone (Gonal-F; Serono Laboratories,
Aubonne, Switzerland) and human menopausal gonado-
tropin (Menopur; Ferring GmbH, Kiel, Germany) were
administered daily, beginning on the second day of the
menstrual cycle. The doses were adjusted according to
the patient’s individual ovarian response. When the
dominant follicle reached a mean diameter of 12 mm,cetrorelix (Cetrotide; Serono Laboratories, Baxter On-
cology GmbH, Halle, Germany) was administered sub-
cutaneously at a dose of 0.25 mg daily until the day of
human chorionic gonadotropin (hCG; Serono Laborator-
ies) administration.
Ovulation was induced with 10,000 IU of hCG when
the patients had ≥ two follicles with diameter > 17 mm.
Oocytes were retrieved 34–36 h after hCG administra-
tion under guided vaginal sonography and exposed to
spermatozoa for insemination. Upon completion of oo-
cyte collection and IVF/ICSI, embryos were graded mor-
phologically by two senior embryologists.
Oocytes exhibiting two pronuclei (2PN) and two polar
bodies 16-20 h after insemination/ICSI were further in-
cubated for embryonic development.
Those displaying two pronuclei were sequentially cul-
tured further in groups up to the blastocyst stage (Day
5) in a humidified atmosphere containing 5 % O2 and
6 % CO2. Blastocyst quality was defined according to the
criteria presented by Gardner and Schoolcraft [11] and
briefly described as follows: Blastocysts were graded
from 1 to 6 based on their degree of expansion and
hatching status (from blastocoeles less than half of the
volume of the embryo (grade 1) to hatched blastocyst
(grade 6)). For blastocysts of grades 3 to 6, inner cell
mass (ICM) and trophectoderm (TE) were also evaluated
and graded accordingly. The ICM was graded into three
categories: A (many ICM cells packed together tightly),
B (several ICM cells grouped loosely) and C (very few
ICM cells). The trophectoderm was also graded into
three categories: A (many trophectoderm cells forming a
multiple epithelium layer), B (few trophectoderm cells
consisting of a loose epithelium layer) and C (very few
trophectoderm cells). In this study, we defined good-
quality blastocysts as ≥ 3AA; 3, 4, 5, 6, AB, BA, BB and
AC. We defined poor-quality blastocysts as ≤ 3BB; 3, 4,
5, 6 and CA. Additionally, we defined the other two
groups based on the rate of blastocyst formation and
quality: the high day 5 good blastocyst group (high day
5 GB group) (day 5 embryonic blastocyst rate ≥ 50 % and
high-quality blastocyst rate ≥ 50 %) and the low day 5
good blastocyst group (low day 5 GB group) (day 5 em-
bryonic blastocyst rate < 50 % and high-quality blastocyst
rate < 50 %). According to these two groups, we calcu-
lated the oocyte maturation rate and the oocyte
fertilization rate.
Collection of ovary follicular fluid
The ovary follicular fluid was collected following the
procedures previously described by Rosen et al. [12] and
Lee et al. [13]. Each follicle was pierced with a single
lumen needle and completely aspirated by ultrasound-
guided aspiration. Follicular fluids of each patient were
pooled. After oocyte removal, follicular fluid samples
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and granulosa cells. Finally, the supernatant was ali-
quoted into 2 ml cryovials and stored at −80 °C until as-
says could be performed.
Zymography for the assay of gelatinolytic activity
The activities of gelatinases (MMP-2 and MMP-9) in fol-
licular fluid were carried out using zymography, as pre-
viously described by our laboratory [14, 15]. Briefly,
follicular fluid samples were analyzed by the gels con-
taining gelatin (0.1 % w/v). Each lane of zymographic gel
was loaded with a constant volume of the samples of fol-
licular fluid. After electrophoresis, gels were incubated
overnight at 37 °C in Tris buffer (pH 8) with 5 mM
CaCl2. Finally, the gels were stained with Coomassie
blue, and the gelatinolytic activities were presented as
transparent bands on the blue background. Gelatinolytic
activities were identified as clear zones and calculated
densitometric value of the lyses against a dark blue back-
ground on zymography gels using ImageJ software (Na-
tional Institutes of Health, Bethesda, MD, USA), which
quantified both the surface and the intensity of the lysis
bands after scanning of the gels according to a previous
report by Hu and Beeton [16]. The levels of MMP-2
and MMP-9 gelatinolytic activity are presented as arbi-
trary units representing the densitometric concentra-
tions after standardization with levels of recombinantFig. 1 Representative MMP-2 and MMP-9 zymography gel of human follicula
Materials and Methods. The gel was analyzed by 8 % SDS-PAGE and follo
compared with MMP-9 activity detected in the follicular fluids. The zymo
quantify proMMP-2 and proMMP-9 activity. The representative gel shows
maturity) and 4 patients with <100 % MII oocytes (low oocyte maturity), as w
MMP-9 (92 kDa) and MMP-2 (72 kDa) on the zymography gel were indicatedMMP-2 (#M9070; Sigma-Aldrich, St. Louis, MO, USA)
and MMP-9 (#M8945; Sigma-Aldrich) as controls in
the same gel, respectively, according to the study of Lee
et al. [13] and Sessions et al. [17].
Representative MMP zymography assay of ovary fol-
licular fluid was shown in Fig. 1. Almost of MMP-2 and
MMP-9 detected in the sample of follicular fluids is la-
tent form in the present study. Therefore, in this study,
we could only detect and discuss the latent form of
MMP-2 and MMP-9.Enzyme-linked immunosorbent assay (ELISA) for TIMPs
The concentrations of TIMPs in follicular fluid were de-
termined using human TIMP-1 and TIMP-2 ELISA kits
(Abcam, Cambridge, MA, USA) according to the manu-
facturer’s recommendations. The samples were diluted
appropriately to fall within the standard range of the assay.
Each recombinant human TIMP-1 and TIMP-2 provided
in the ELISA kits was used as a standard. The diluted fol-
licular fluid was incubated in ELISA plates in which wells
had been coated with anti-human TIMP-1 and TIMP-2
primary antibodies. Following the addition of biotinylated
secondary antibodies, the plates were washed and reacted
with horseradish peroxidase (HRP)-conjugated streptavi-
din. Tetramethylbenzidine (TMB) one-step substrate was
used to detect the targeted protein and the product wasr fluids. Zymography assay was performed as described in the section of
wed by Coomassie staining. There was related higher MMP-2 activity
graphy gel was loaded with 5 μl of samples diluted 5× in PBS to
follicular fluids from 4 patients with 100 % MII oocytes (high oocyte
ell as one control lane with recombinant proMMP-2 and proMMP-9.
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Scientific Multiskan EX, Waltham, MA, USA).
Statistical analysis
The data were analyzed using SPSS (version 19.0 for
Windows; SPSS, Chicago, IL, USA). All parameters are
presented as the mean with the standard deviation (SD).
Pearson’s test was used for correlation analysis between var-
iables. Significant differences between the subgroups were
evaluated using one-way analysis of variance (ANOVA). A
P value of < 0.05 was considered statistically significant.
Results
In the present study, 150 women who underwent IVF/
ICSI cycles were analyzed. The patients’ characteristics
are shown in Table 1. A total of 1504 oocytes were re-
trieved and 1346 of them were metaphase 2 (MII) oo-
cytes. The mean number of MII oocytes per patient was
9.1 ± 6.2. The MII oocyte ratio was 91.3 %. Approxi-
mately 956 embryos were normally fertilized (i.e., 2PN
embryos) and 430 of them developed good-quality blas-
tocysts at day 5 (i.e., D5 GB embryos) (Table 1). The
2PN embryo ratio and the D5 GB embryo ratio were
71.4 and 35.6 %, respectively.
MMPs and TIMPs in follicular fluid
In the follicular fluid samples from all women, the MMP-
2 and MMP-9 activities were 18.4 ± 4.51 and 2.13 ± 6.49Table 1 Characteristic measurements of IVF/ICSI women
Number of patients 150
Age (years) 35.2 ± 4.4
Serum estradiol (pg/ml) 2692 ± 1589
Serum progesterone (ng/ml) 0.73 ± 0.54
Mean number of retrieved oocytes 10.2 ± 6.8 (1504)
Mean number of MII oocytes 9.1 ± 6.2 (1346)
MII oocyte ratio (%) 91.3 ± 14.9 (1346/1504)
Mean number of 2PN embryos 6.5 ± 4.8 (956)
2PN embryo ratio (%) 71.4 ± 24.2 (956/1346)
Mean number of D5 GB embryos 3.0 ± 3.9 (430)
D5 GB embryo ratio (%) 35.6 ± 33.9 (430/956)
MMPs in follicular fluid
MMP-2 (Arbitrary units/μl) 18.4 ± 4.51
MMP-9 (Arbitrary units/μl) 2.13 ± 6.49
TIMPs in follicular fluid
TIMP-1 (ng/ml) 117 ± 35
TIMP-2 (ng/ml) 54.5 ± 15.5
MII Metaphase II, 2PN Two pronuclei, D5 GB good-quality blastocysts on day 5
MMP Matrix metalloproteinase, TIMP Tissue inhibitor of matrix metalloproteinase
Values are expressed as the mean ± SD. The values in parentheses indicate the
numbers of oocytes or embryos(arbitrary units/μl), respectively. The TIMP-1 and TIMP-2
levels were 117 ± 35 and 54.5 ± 15.5 ng/ml, respectively
(Table 1). To evaluate the relationships between serum E2
and progesterone concentrations, MMP activity, TIMP
level, maturation rate, fertilization rate of oocytes and day
5 good-quality blastocyst rate, the Pearson correlation co-
efficient was analyzed. The data indicated that MII% are
significantly and positively correlated to follicular MMP-2
activity (r = 0.261; P < 0.01). However, the day 5 good-
quality blastocyst rate had no significant correlation to the
activity of follicular MMPs and TIMPs (data not shown).
According to these results, we proposed that the MMP-2
is a reliable factor associated with oocyte maturation in
IVF/ICSI cycles.
Association of oocyte maturation rate with MMP-2
To further investigate the relationship between gelatinases
and the high as well as low maturity rate of oocytes re-
trieved, the patients were divided into two groups: the
high oocyte maturity group (MII ratio = 100 %; n = 95)
and the low oocyte maturity group (MII ratio < 100 %;
n = 55) (Table 2). In our clinic, only follicles ≥ 16 mm
were retrieved. More than half of our cases had an oo-
cyte maturation rate = 100 % (n = 95). To avoid statis-
tical bias, we defined the cut-point as an oocyte
maturation rate =100 %. The results show that there
were no differences between two groups in serum E2
level, serum progesterone level, 2PN embryo ratio, andTable 2 MMP and TIMP activities in the follicular fluid between
high and low oocyte maturity groups
High oocyte
maturity group
(MII oocytes = 100 %)
Low oocyte
maturity group





Estradiol (pg/ml) 2774 ± 1078 2651 ± 1829 NS
Progesterone
(ng/ml)
0.81 ± 0.78 0.69 ± 0.39 NS
MII oocytes ratio
(%)
100 ± 0 76.4 ± 15.8 < 0.001
2PN embryos
ratio (%)
75.9 ± 24.4 68.8 ± 23.8 NS
D5 GB embryos
ratio (%)
45.8 ± 32.5 29.8 ± 33.5 < 0.01
MMP-2 (Arbitrary
units/μl)
19.6 ± 4.3 16.3 ± 4.3 < 0.001
MMP-9 (Arbitrary
units/μl)
2.11 ± 0.59 2.19 ± 0.74 NS
TIMP-1 (ng/ml) 123 ± 37 107 ± 26 NS
TIMP-2 (ng/ml) 54.6 ± 16.5 52.6 ± 13.6 NS
MII Metaphase II, 2PN Two pronuclei, D5 GB Good-quality blastocysts on day 5,
MMP Matrix metalloproteinase, TIMP Tissue inhibitor of matrix metalloproteinase
Values are expressed as the mean ± SD. P values are comparisons between the
high- and low-maturity groups by ANOVA.; NS: no statistical significance
(i.e., P > 0.05)
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however, the activity of MMP-2 in follicular fluid was
increased in the high maturity oocyte group (19.6 ± 4.3
vs.16.3 ± 4.3 (arbitrary units/μl), P < 0.001) (Table 2).
The D5 GB ratio was significantly higher in the high ma-
turity oocyte group (45.8 ± 32.5 vs. 29.8 ± 33.5, P < 0.01).Association of formation rate of two pronuclei (2PN) with
MMPs and TIMPs
To investigate the relationships between gelatinase activ-
ity and the oocyte fertilization, we divided patients into
another two groups: the low fertilization rate group
(2PN rate < 70 %; n = 84) and the high fertilization group
(2PN rate ≥ 70 %; n = 66) (Table 3). There were no sig-
nificant differences in the serum level of E2, the serum
level of progesterone, MMP-9, TIMP-1 and TIMP-2 in
follicular fluid between two groups. There was a signifi-
cant difference in follicular fluid MMP-2 level between
the high and low fertilization rate groups (19.4 ± 4.2 vs.
17.5 ± 4.6 (arbitrary units/μl), P < 0.01) (Table 3). The
MII oocyte ratio was significantly higher in the high
fertility rate group (95.2 ± 11.9 vs. 88.3 ± 16.3, P < 0.01)
and the 2PN embryo ratio was significantly elevated in
the high fertility rate group (88.5 ± 11.0 vs. 49.6 ± 18.1,
P < 0.001). The D5 GB embryo ratio was also higher in
the high fertility rate group (42.8 ± 33.4 vs.26.6 ± 32.5,
P < 0.01).Table 3 MMP and TIMP activities in the follicular fluid between
the high and low percentage successful fertilization groups
High fertility rate
group (2PN≥ 70 %)
Low fertility rate
group (2PN < 70 %)
P value
Number of patients 84 66
Estradiol (pg/ml) 2689 ± 1588 2707 ± 1611 NS
Progesterone
(ng/ml)
0.72 ± 0.49 0.74 ± 0.60 NS
MII oocytes ratio (%) 95.2 ± 11.9 88.3 ± 16.3 < 0.01
2PN embryos ratio
(%)
88.5 ± 11.0 49.6 ± 18.1 <
0.001
D5 GB embryos ratio
(%)
42.8 ± 33.4 26.6 ± 32.5 < 0.01
MMP-2 (Arbitrary
units/μl)
19.4 ± 4.2 17.5 ± 4.6 < 0.01
MMP-9 (Arbitrary
units/μl)
2.14 ± 0.70 2.10 ± 0.59 NS
TIMP-1 (ng/ml) 117 ± 32 120 ± 35 NS
TIMP-2 (ng/ml) 55.1 ± 15.1 53.2 ± 17.0 NS
MII Metaphase II, 2PN Two pronuclei, D5 GB Good-quality blastocysts on day 5,
MMP Matrix metalloproteinase, TIMP Tissue inhibitor of matrix metalloproteinase
Values are expressed as the mean ± SD. P values are comparisons between the
high and low percentage successful fertilization groups by ANOVA. NS: no
statistical significance (i.e., P > 0.05)Association of good quality blastocysts at day 5 (D5 GB)
with MMPs and TIMPs
To investigate the relationships between gelatinase activ-
ity and the day 5 good quality blastocyst formation rate,
we divided patients to two groups: the high day 5 good
blastocyst group (high day 5 GB group) (day 5 embry-
onic blastocyst rate ≥ 50 % and high quality blastocyst
rate ≥ 50 %; n = 59) and low day 5 good blastocyst group
(low day 5 GB group) (day 5 embryonic blastocyst rate <
50 % and high quality blastocyst rate < 50 %; n = 91).
There were no significant differences in the serum level of
estradiol, progesterone, MII oocytes ratio, follicular fluid
level of MMP-2, MMP-9, TIMP-1, and TIMP-2 (Table 4).Discussion
In this study, we showed that the follicular fluid MMP-2
level during IVF/ICSI treatment had a significant correl-
ation with the oocyte maturation rate (Table 2). In
addition, there was no correlation between the oocyte
maturation rate with MMP-9, TIMP-1 and TIMP-2 in
follicular fluid. Furthermore, we suggested that the
MMP-2 level in follicular fluid was significantly higher
in the high fertility rate group (2PN ≥ 70 %) (Table 3).
The accurate volume of follicular fluids was hard to ob-
tain, therefore a constant volume was used instead in
each patient. There are more fluids expected in larger
follicles, which contain mature oocytes. The diluting ef-
fect in larger follicles would have presumably resulted in
less proMMP-2 activity, which was not observed in ourTable 4 MMP and TIMP activities in the follicular fluid between
high and low D5 GB embryo groups
High D5 GB group
(D5 GB ≥ 50 %)
Low D5 GB group
(D5 GB < 50 %)
P value
Number of patients 59 91
Estradiol (pg/ml) 2937 ± 1362 2541 ± 1715 NS
Progesterone (ng/ml) 0.83 ± 0.76 0.68 ± 0.36 NS
MII oocytes ratio (%) 89.7 ± 14.6 92.4 ± 15.0 NS
2PN embryos ratio (%) 77.0 ± 21.0 67.7 ± 25.5 < 0.05
D5 GB embryos ratio
(%)
72.4 ± 16.3 11.8 ± 16.5 < 0.001
MMP-2 (Arbitrary
units/μl)
17.2 ± 4.3 19.1 ± 4.5 NS
MMP-9 (Arbitrary
units/μl)
2.25 ± 0.66 2.04 ± 0.63 NS
TIMP-1 (ng/ml) 114 ± 30 120 ± 36 NS
TIMP-2 (ng/ml) 54.9 ± 14.8 54.3 ± 16.1 NS
MII Metaphase II, 2PN Two pronuclei, D5 GB Good-quality blastocysts on day 5,
MMP Matrix metalloproteinase, TIMP Tissue inhibitor of matrix metalloproteinase
Values are expressed as the means ± SD. P values are comparisons between
the high and low D5 GB embryo groups by ANOVA.; NS: no statistical
significance (i.e., P > 0.05)
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an increased production of proMMP-2 in mature follicles.
To the best of our knowledge, the present study was
the first study to find human follicular fluid MMP-2
level could predict oocyte maturation in IVF/ICSI cycles.
In IVF/ICSI treatment, oocyte maturation based on the
size of leading follicles (> 17 mm) and combined with
serum E2 level (assumed elevation level of serum E2 is
approximately 150–200 ng/dl per mature oocyte) could
be useful in the clinical prediction of oocyte maturation.
However, these predictions were not always accurate. In
the present study, we showed that the follicular fluid
MMP-2 level was not only significantly correlated to the
maturation rate of oocytes but also strongly correlated
to the normal fertilization rate. In addition, the serum
E2 level was not significantly correlated to the oocyte
maturity rate and fertility rate (Tables 2 and 3). These
data indicate that MMP-2 might play a major role in oo-
cyte maturation and further fertilization.
According to the study of Brew et al. [8], it was re-
ported that the MMP-TIMP system is implicated in the
proteolysis network of follicular development and the
breakdown of the follicular wall during successful ovula-
tion. In an in vitro culture study involving bovine folli-
cles, the secretion of MMP-9, TIMP-1 and TIMP-2 was
shown to be associated with follicular health [18]. The
IVF/ICSI patients with higher levels of MMPs, espe-
cially MMP-9, in the follicular fluid and serum at the
time of oocyte retrieval, had higher pregnancy rates
after embryo transfer [13, 19]. The levels of MMP ex-
pression and activity during follicular development,
however, have been reported inconsistently. Compared
with MMPs in the follicular fluid of IVF/ICSI patients
and normal ovulating women, the MMP-2 and MMP-9
levels were much lower in IVF/ICSI patients [3]. Re-
cently, some evidence has shown that MMP-2 may play
a role in follicular development and MMP-9 might be
involved in follicular breakdown [4]. Compared with
MMPs, the changes in the follicular TIMPs related to
oocyte maturation and fertilization have received lim-
ited attention. In infertile patients, an increase in the
follicular TIMP-1, but not TIMP-2, level was detected
compared with that in the normally ovulating control
group. According to the results, multiple and important
functions of ovarian TIMP-1 during the folliculogenesis
and ovulation process were proposed [20, 21]. However,
reports of significant differences between the groups
with altered performance in infertile patients are lack-
ing, such as oocyte in vitro maturation and fertilization.
The previous study showed that MMP expression was
elevated while TIMP expression was reduced at the
time of ovulation [22]; others had concluded that the
high level of TIMPs was unchanged during follicular
development [23]. In the present study, we found thatthe concentrations of TIMP levels, including TIMP-1
and TIMP-2, in follicular fluid were not related to the
oocyte maturation rate (Table 2). Furthermore, the TIMPs
were not correlated to the normal fertilization rate of em-
bryos (Table 3). These findings were compatible with the
previous study [2].
In controlled ovarian hyper-stimulation cycles, evi-
dence showed epidermal growth factor receptor (EGFR)
signaling as a key factor to coordinate LH-mediated events
[24–26]. Furthermore, this EGFR activation was required
for MMP-mediated release of membrane-bound EGFR li-
gands [27, 28]. Similar effects of EGFR phosphorylation and
gonadotropin-induced oocyte maturation were shown to be
diminished after inhibiting MMP activity in ovarian follicles
[24, 25, 29]. It had also been reported that an increase in bo-
vine MMPs was clearly associated with subsequent blasto-
cyst development during in vitro maturation [30]. In the
previous studies, the inhibition of MMP-2 activity signifi-
cantly decreased the fertilization rate [31, 32]. Compatible
with previous studies, we found that MMP-2 activity was
significantly correlated to the maturation rate of oocytes
(Table 2). According to the findings above, we proposed
that MMP-2 might play a crucial role during oocyte
maturation.
Mammalian fertilization requires the penetration of
the sperm through the zona pellucida of oocytes. Defect-
ive sperm-zona pellucida interaction, including harden-
ing of the zona pellucida, may cause fertilization failure.
Therefore, to further penetrate the zona pellucida for
fertilization is important, especially in IVF treatment [33].
Several proteolysis regulators, including MMP-2, TIMP-1,
TIMP-2 and TIMP-3, have been detected in seminal fluid
and are important for mammalian sperm function in
fertilization [9]. In addition, female-expressed proteolysis
regulators are also essential, as they may act together with
male-derived proteases and protease inhibitors in post-
mating proteolysis networks. In the previous study, MMP-
2 activity was shown to associate with the inner acrosomal
membrane of sperm; the proteolytic activity might im-
prove sperm penetration in the zona pellucida [31]. In our
study, MMP-2 activity in the follicular fluid of women
undergoing IVF/ICSI showed a significant surge in the
high oocyte maturity and high fertilization rate subgroups.
It was reasonable to think that when oocytes were going
to mature, the MMP-2 showed advanced activity in the
follicular fluid to prepare for further fertilization. If the fol-
licular fluid MMP-2 level was a marker of oocyte matur-
ation, then serum MMP-2 level might be a reliable marker
as well. Further studies on serum MMP-2 levels can be
performed to prove this hypothesis. This finding further
suggests that MMP-2 might be an important enzyme to
improve the function of matured oocytes during the
oocyte-sperm interaction and increase the successful rate
of fertilization during IVF/ICSI.
Yang et al. Reproductive Biology and Endocrinology  (2015) 13:102 Page 7 of 8In conclusion, MMP-2 level in follicular fluid during
IVF/ICSI was significantly correlated with the maturation
rate of oocytes. Furthermore, MMP-2 activity also had a
strong correlation with the higher fertilization rate. MMP-
2 activity in follicular fluid in IVF/ICSI cycles may be a re-
liable marker of the oocyte maturation rate. However, fur-
ther studies are warranted to confirm these findings.
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